Here’s why you should hold Myriad Genetics (MYGN) Stock now

Zacks Investment Research

A myriad of genetics (MYGN Quick quoteMYGN – Free Report) is well-prepared for growth in the coming quarters, supported by the strength of its oncology business. The company has launched a number of products in recent months. Progress in its transformation plan, growth initiatives and planned divestitures will provide MYGN with a foundation for continued … Read more